Literature DB >> 3260568

Gastric adaptation. Studies in humans during continuous aspirin administration.

D Y Graham1, J L Smith, H J Spjut, E Torres.   

Abstract

To study the process of gastric mucosal adaptation to aspirin administration, 14 normal men underwent a study with continued administration of aspirin. Endoscopic assessment, biopsies, and gastric wash collections for acid, mucus, and deoxyribonucleic acid recovery were performed weekly; aspirin was continued until the endoscopy showed minimal damage. Six subjects took 650 mg of aspirin b.i.d., and 8 took 650 mg q.i.d.; adaptation and resolution took longer with the higher dose (median 4.5 wk vs. 1 wk, p less than 0.01). Despite improvement in mucosal appearance, gastric microbleeding remained elevated throughout aspirin administration. In contrast, deoxyribonucleic acid recovery (a marker for cellular exfoliation and regeneration) increased significantly just before the time of resolution, when, on average, it more than doubled. As no other biochemical or histologic changes could be associated with the resolution of damages, we conclude that gastric adaptation to chronic injury may involve increased cellular regeneration.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3260568

Source DB:  PubMed          Journal:  Gastroenterology        ISSN: 0016-5085            Impact factor:   22.682


  48 in total

1.  Nonsteroidal anti-inflammatory drugs and ulcers.

Authors:  A H Soll
Journal:  West J Med       Date:  1992-10

2.  Placebo-controlled comparison of piroxicam-beta-cyclodextrin, piroxicam, and indomethacin on gastric potential difference and mucosal injury in humans.

Authors:  L Santucci; S Fiorucci; S Chiucchiù; A Sicilia; L Bufalino; A Morelli
Journal:  Dig Dis Sci       Date:  1992-12       Impact factor: 3.199

Review 3.  Non-steroidal anti-inflammatory drugs and peptic ulcers.

Authors:  C J Hawkey
Journal:  BMJ       Date:  1990-02-03

4.  Effects of nonsteroidal anti-inflammatory drugs on Helicobacter pylori-infected gastric mucosae of mice: apoptosis, cell proliferation, and inflammatory activity.

Authors:  T I Kim; Y C Lee; K H Lee; J H Han; C Y Chon; Y M Moon; J K Kang; I S Park
Journal:  Infect Immun       Date:  2001-08       Impact factor: 3.441

Review 5.  Prophylaxis against non-steroidal induced upper gastrointestinal side effects.

Authors:  I Barrison
Journal:  Ann Rheum Dis       Date:  1991-04       Impact factor: 19.103

Review 6.  Pathologic basis of gastric mucosal adaptation to topical injury.

Authors:  J Stachura; S J Konturek; T Brzozowski; J Konturek; W Domschke
Journal:  J Gastroenterol       Date:  1995-06       Impact factor: 7.527

7.  Chemical gastritis and Helicobacter pylori related gastritis in patients receiving non-steroidal anti-inflammatory drugs: comparison and correlation with peptic ulceration.

Authors:  A S Taha; I Nakshabendi; F D Lee; R D Sturrock; R I Russell
Journal:  J Clin Pathol       Date:  1992-02       Impact factor: 3.411

8.  Mucosal adaptation to indomethacin induced gastric damage in man--studies on morphology, blood flow, and prostaglandin E2 metabolism.

Authors:  C J Shorrock; W D Rees
Journal:  Gut       Date:  1992-02       Impact factor: 23.059

9.  Reflux gastritis in the intact stomach.

Authors:  G M Sobala; R F King; A T Axon; M F Dixon
Journal:  J Clin Pathol       Date:  1990-04       Impact factor: 3.411

10.  Increased gastric juice epidermal growth factor after non-steroidal anti-inflammatory drug ingestion.

Authors:  S M Kelly; J R Jenner; R J Dickinson; J O Hunter
Journal:  Gut       Date:  1994-05       Impact factor: 23.059

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.